PTPN11 and RASopathy: Finally, in an integrated approach using a platform of 13 transgenic fruit-flies expressing human RASopathies variants in CRAF, BRAF, KRAS and PTPN11 the phenotypic differences by distinct variants were identified, as well as the responses to a wide range of therapeutic treatments and differences in downstream signaling (Das et al., 2021).